Answers are grounded in this paper and cite their sources.
CPAH is a prevalent and severe form of pulmonary arterial hypertension with a poor prognosis, particularly in systemic sclerosis patients where mortality can reach 50% within 1 year without treatment.
onnective disease (CTD)-associated pulmonary arterial hypertension (CPAH) is the second most alent type of pulmonary arterial (PAH) after idiopathic PAH (IPAH). CPAH is estimated to account for 30% of all adult cases of PAH. Approximately 15% mixed CTD (MCTD), 10% of systemic sclerosis (SSc), and several percent of systemic lupus erythematosus (SLE) patients develop PAH. 1-3 In general, patients with CPAH have a poorer prognosis than those with other forms of PAH, except for pulmonary veno-occlusive disease (PVOD). 4 A half of SSc patients may die within 1 year of PAH diagnosis without any treatment.
No takes yet. Share an insight, caveat, or question.
Takeuchi et al. (2011) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: